Hormone-Refractory Prostate Cancer

or Castrate-Resistant Prostate Cancer

Understanding    Treating    Maintaining Quality of Life

Home
What's New
News
What To Do First
Patient's Guide
E-mail Support Group
Proven Treatments
Potential Treatments
Managing Symptoms
Diagnostic Tests
Information Resources
FAQ
Support HRPCA.org

 

 

NEWS & USEFUL INFORMATION 

This page provides some of the latest news and useful information related to hormone refractory prostate cancer.  The newest items appear at the top of the list.

3/1/13 - "The Changing Landscape in the Treatment of Metastatic Castration-resistant Prostate Cancer"

This is another excellent article that describes the recent advances in the treatment of HRPC/CRPC.  It is by Joelle El-Amm, MD, Jeanny B. Aragon-Ching, MD, FACP; Ther Adv Med Oncol. 2013;5(1):25-40. (Signing up to access Medscape is free.)

http://www.medscape.com/viewarticle/777315?src=nl_topic

2/5/13 - Cheat Sheet of Drug Names

All of the new drugs and treatments have had several names during the course of their development.  It's enough to drive a person crazy.  Here is a cheat sheet.
 
Generic Name Brand Name Therapy Type - How Administered
Approved    
Abiraterone Ztiga Hormonal Therapy - Oral
Cabazitaxel Jevtana Cytotoxic Therapy - Infusion
Denosumab Xgeva Bone-Directed Therapy - SC Injection
Docetaxel Taxotere Cytotoxic Therapy - Infusion
MDV3100 (Enzalutamide) Xtandi Hormonal Therapy - Oral
Sipuleucel-T Provenge Immunotherapy - Leukapheresis-like Infusion
     
Not Yet Approved    
Cabozantinib (XL184) Cometriq Targeted Therapy - Oral
Dasatinib Sprycel Bone-Directed Therapy - Oral
Prostvac   Immunotherapy - Subcutaneous Injection
Radium-223 Alpharadin Bone-Directed Therapy - Infusion
Tasquinimod   Immunotherapy - Oral
     

2/5/13 - Overview of CRPC Management and Novel Therapeutics

An excellent summary of the latest developments in treatments for HRPCa appeared in CA A Cancer Journal for Clinicians in 2012:

Clinical Development of Novel Therapeutics for Castration-Resistant Prostate Cancer
CA: A Cancer Journal for Clinicians
Matthew D. Galsky, Alexander C. Small, Che-kai Tsao, William K. Oh
DOI: 10.3322/caac.21141

http://onlinelibrary.wiley.com/doi/10.3322/caac.21141/full

Another excellent overview of recent progress is a paper by Oliver Sartor, M.D.:
State-of-the-Art Management for the Patient with Castration-Resistant Prostate Cancer in 2012, ASCO

http://www.asco.org/ASCOv2/Home/Education%20&%20Training/Educational%20Book/PDF%20Files/2012/zds00112000289.PDF

2/4/13 - Understanding your Bone Scan

Jan Manarite wrote a very informative article on bone scans for the PRCI Insights Newsletter.  Click here to read.

2/4/13 - Dealing with HRPCa

If you are dealing with HRPCa, this book would be good to read and keep handy:  Promoting Wellness - Beyond Hormone Therapy - Options for Prostate Cancer Patients. Mark A. Moyad, M.D., M.P.H., Spry Publishing, an imprint of Ann Arbor Editions, LLC, 2011.

7/26/12 -  This NEWS section was added by webmaster Howard Hansen at the time when a whole bunch of new therapies for HRPCa were in the final stages of testing.  He proposed to use it to post promising results and drug approvals as they happened.  Sadly his own cancer was giving him more trouble around this time and he succumbed to HRPCa in 2010.  We will use this page to provide news and information of interest to those facing HRPCa.


 

 

This information related to HRPCa, AIPC, and/or CRPC is provided for educational purposes only and does not replace or amend professional medical advice. Unless otherwise stated and credited, the content of this website is by and the opinion of and copyright © 2001-2013 Howard Hansen and/or HRPCa Association, Inc.  All Rights Reserved.  Our policy regarding privacy, right to reprint and contact information are at About Us. We are a 501(c)(3) not-for-profit public charity.